Caring for Kids with Cancer Symposium

Miami, FL US
October 19, 2019

This symposium will highlight a spectrum of new developments and innovative advances in current pediatric oncology practice. The faculty — including leading experts from the top local and national cancer care institutions — will review the latest technologies and therapeutic approaches to challenging clinical problems, and will focus on evidence-based approaches to the special physical, emotional and psychological needs of pediatric cancer patients and their families.
Working in partnership to provide the best possible care for the communities they serve, two local leaders in healthcare – Miami Cancer Institute, part of Baptist Health South Florida, the area's largest, not-for-profit healthcare provider, and nonprofit Nicklaus Children's Hospital, part of Miami Children's Health System and the leading provider of children's healthcare services in South Florida – are collaborating to improve healthcare through continuing education.

Complete details at MiamiCancerInstitute.com/CaringforKids

Registration Fee is $35.00

Target Audience

Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, ED Physicians, Psychiatrists, Psychologists, Nurses, Respiratory Therapists, Occupational Therapists, Pharmacists, Dietitians and all interested healthcare providers who care for children with cancer.

Learning Objectives

  • Describe and be familiar with current T-cell therapy approaches. 
  • Examine and have a better understanding on how T-cells are generated and currently used in the clinic. 
  • Analyze challenged and opportunities in developing T-cell therapies for pediatric cancer. 
  • Summarize the meaning and use of histologic necrosis following initial chemotherapy in the treatment of osteosarcoma.  
  • Describe the evolving role of genomic profiling in the diagnosis and treatment of osteosarcoma. 
  • Implement intraoperative MRI, computed tomography and ultrasound to maximize the extent of tumor resection in a single sitting. 
  • Describe intraoperative neurophysiological monitoring that has been successful to assist in the safe remover of tumors in eloquent areas of the brain. 
  • Describe selected pediatric cancer diagnosis and associated nutrition risks and complications. 
  • Identify caregivers who would benefit from nutrition referral to assist with nutrition care planning responsibilities during selected treatment roadmaps.  
  • Discuss available nutrition guidelines and best practice for the pediatric cancer patient survivor.  
  • Apply tumor precision diagnostics in order to improve patient care. 
  • Assess molecular studies that have led to the identification of distinct tumor subgroups in pediatric brain tumors. 
  • Describe current CD19 CAR T-cell therapy outcomes and limitations. 
  • Assess and familiarize the onset, optimal management and results of anti-tumor efficacy of CAR T-cell toxicities. 
  • Describe the value of dose intensity in the treatment of newly diagnosed EWING sarcoma. 
  • Analyze the controversy around the use of high dose therapy with autologous stem cell support in the treatment of Ewing sarcoma.  
  • Describe robotic surgery in pediatric cancer care. 
  • Analyze potential usage of robotic surgery in pediatric cancer. 
  • Demonstrate pediatric cancer surgery case presentations
  • Identify selected pediatric cancer diagnosis and associated nutrition risks and complications. 
  • Discuss nutrition risks associated with pediatric cancer. 
  • Discuss common nutrition diagnosis associated with pediatric cancer treatment modalities.  
Course summary
Available credit: 
  • 5.50 Florida Board of Dietitians
  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Florida Board of Nursing
  • 5.50 Nurse Practitioners
  • 5.50 Florida Board of Occupational Therapy
  • 5.50 Florida Board of Pharmacy
  • 5.50 Florida Board of Psychology
  • 5.50 Florida Board of Respiratory Therapy
  • 5.50 General certificate of attendance
Course opens: 
05/15/2019
Course expires: 
12/28/2019
Event starts: 
10/19/2019 - 8:00am
Event ends: 
10/19/2019 - 1:15pm
Cost:
$35.00
Rating: 
0

7:30 – 7:50 a.m.            Registration and Breakfast

7:50 a.m.                      Welcome and Introductions

8:00 a.m.                      Immunotherapy in Pediatric Tumors - Stephen Gottschalk, M.D.

8:45 a.m.                      Osteosarcoma Update - Paul A. Meyers, M.D.

9:10 a.m.                      Questions and Answers - Stephen Gottschalk, M.D. and Paul A. Meyers, M.D.

9:25 a.m.                      Update on Neurosurgical Advances in Pediatric Tumors -  Toba N. Niazi, M.D.

9:50 a.m.                      Pediatric Nutrition and Oncology -  Dominique Symonette, M.S., RDN

10:15 a.m.                     Questions and Answers - Toba N. Niazi, M.D. and Dominique Symonette, M.S., RDN

10:30 a.m.                     Break and Visit Exhibits

10:50 a.m.                     Molecular Classification of Brain Tumors - Michael D. Taylor, M.D., Ph.D.

11:35 a.m.                     CAR T Cells for Solid Tumors: What are the Challenges? - Stephen Gottschalk, M.D.

12:00 p.m.                    Questions and Answers - Michael D. Taylor, M.D., Ph.D. and Paul A. Meyers, M.D.

12:15 p.m.                    Break and Exhibits

12:35 p.m.                    Ewing Sarcoma Update - Paul A. Meyers, M.D.

1:00 p.m.                      Robotics as enhancement to cancer surgery in children  - Faud Alkhoury, M.D.  

1:25 p.m.                      Managing Treatment Side Effects and Maintaining Proper Nutrition - Dominique Symonette, M.S., RDN

1:50 p.m.                      Questions and Answers - Paul A. Meyers, M.D., Toba N. Niazi, M.D. and Dominique Symonette, M.S., RDN

2:05 p.m.                      Adjourn

Miami Cancer Institute
8900 N. Kendall Dr
Cafe
Miami, FL 33176
United States

Parking: The special event parking garage will be open behind the Miami Cancer Institute.
Approach from SW 88 Street (Kendall Drive).​​

 

Symposium Directors:

Doured Daghistani, M.D.
Symposium Director

Hematology/Oncology
Baptist, Homestead, South Miami Hospitals
Miami, Florida

Doured Daghistani, M.D., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Ziad  Khatib, MD 
Director of Medical Neuro-Oncology
Division of Pediatric Hematology Oncology
Clinical Associate Professor
Department of Pediatrics
Florida International University
Kidz Medical Services
Nicklaus Children’s Hospital
Miami, Florida

Ziad Khatib, M.D., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Symposium Faculty:

Fuad Alkhoury, M.D. 
Director, Neonatal General Surgery
Niklaus Children’s Hospital
Miami, Florida

Faud Alkhoury, M.D.  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Stephen Gottschalk, M.D. 
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Endowed Chair in Bone Marrow Transplantation and Cellular Therapy
St. Jude’s Children’s Hospital 
Memphis, Tennessee

Stephen Gottschalk, M.D.  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Paul A. Meyers, M.D. 
Pediatric Oncologist
Chief of Sarcoma Service 
Vice Cahir for Clinical Affairs
Memorial Sloan Kettering
New York, New York

Paul A. Meyers, M.D.  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Toba N. Niazi, M.D. 
Pediatric Neurosurgeon
Nicklaus Children’s Hospital 
Miami, Florida

Toba Niazi, M.D.  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Dominique Symonette, M.S., RDN. LDN, CNSC
Clinical Nutritionist Specialist
Miami Cancer Institute
Miami, Florida 

Dominique Symonette, M.S.,  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).

Michael D. Taylor M.D., Ph.D.
Staff Neurosurgeon, Hospital for Sick Children 
Professor, Department of Surgery and,
Department of Laboratory Medicine and Pathobiology
University of Toronto
Toronto, Canada

Michael D. Taylor, M.D.,  indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
 

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 5.5 credit hours by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants. CE Broker #20-726676 .

Approved for a total of 5.5 contact hours by the Florida State Board of Nursing, Dietary, Pharmacy, Occupational Therapy and Respiratory Therapy. CE Broker Provider #50-182.

Additional credits pending.

Available Credit

  • 5.50 Florida Board of Dietitians
  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Florida Board of Nursing
  • 5.50 Nurse Practitioners
  • 5.50 Florida Board of Occupational Therapy
  • 5.50 Florida Board of Pharmacy
  • 5.50 Florida Board of Psychology
  • 5.50 Florida Board of Respiratory Therapy
  • 5.50 General certificate of attendance

Accreditation Period

Course opens: 
05/15/2019
Course expires: 
12/28/2019

Price

Cost:
$35.00
Please login or register to take this course.

Registration Fee is $35.00

Cancellations must be received by October 4, 2019 to receive a refund of the registration fee, less a $25 administrative fee. Registration fees are not refundable after October 4, 2019.

Required Hardware/software

If you are not able to register, please look in the upper right to see if there is something in your shopping cart.

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support